Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database

Keyphrases

• Surveillance Epidemiology 100%
• Carfilzomib 100%
• Associated Risk Factors 100%
• Medicare Database 100%
• Treatment Risk 100%
• Cardiopulmonary Complications 100%
• Cardiac Adverse Events 100%
• Pulmonary Adverse Events 66%
• Chronic Obstructive Pulmonary Disease 33%
• Myeloma 33%
• Risk Factors 11%
• Pneumonia 11%
• Hypertension 11%
• Older Adults 11%
• Clinical Trials 11%
• Cough 11%
• Comorbidity 11%
• Heart Failure 11%
• Adjusted Hazard Ratio 11%
• Medicare 11%
• International Classification of Diseases 11%
• Ninth Revision 11%
• ICD-9 11%
• Dyspnea 11%
• Disease Course 11%
• Respiratory Infection 11%
• Multivariate Cox Regression 11%
• Peripheral Edema 11%
• Linked Database 11%
• Population Needs 11%
• Adverse Events of Interest 11%

Medicine and Dentistry

• Adverse Event 100%
• Medicare 100%
• Surveillance, Epidemiology, and End Results 100%
• Carfilzomib 100%
• Chronic Obstructive Pulmonary Disease 20%
• Myeloma 20%
• Clinical Trial 6%
• Hazard Ratio 6%
• Coughing 6%
• Population 6%
• Proportional Hazards Model 6%
• International Classification of Diseases 6%
• Congestive Heart Failure 6%
• Disease Course 6%
• ICD-9 6%
• Respiratory Tract Infection 6%
• Identified Patient 6%
• Dyspnea 6%
• Peripheral Edema 6%
• Comorbidity 6%